Corporate leaders are increasingly prioritizing results over employee comfort, with CEOs like Unilever's Fernando Fernandez demanding "volu...

Twisha Sharma dowry death: Twisha Sharma's mysterious death has become a complex case with her mother-in-law, a retired judge, alleging dru...

Medics are working to evacuate two individuals with hantavirus symptoms from a luxury cruise ship off West Africa after an outbreak claimed...

Sun Pharma, led by Dilip Shanghvi, has agreed to acquire US-based Organon in an all-cash deal worth $11.75 billion, marking the largest acq...

US company’s board meeting is happening this weekend to finalise decision; an announcement is imminent later tonight or by Monday. Mumbai H...

Sun Pharmaceutical is making its biggest move yet with a $13 billion offer for Organon & Co. This ambitious bid aims to transform the India...

The company is also looking at potential collaborations with Indian biotech firms and contract research organisations for development, manu...

Bayer had approached court in 2016 to stop Alembic Pharmaceuticals from exporting its generic of the German company's blood thinner brand '...

The German watchdog said it will take a decision shortly on whether to add more medicines to the list of banned drugs in the wake of the EM...

Bahr advocating stronger cooperation between Indian and Germany in the health sector, especially in immigration of medical and nursing prof...

Analysts have been pushing Ankur Drugs & Pharma to investors on the premise that the company will benefit from its contract drug manufactur...

German drug co recalled two batches of cancer drug made by its Indian arm on cross-contamination.

Boehringer Ingelheim in talks with Cipla for supply of generic drugs to the $17-bn German coa for two drugs.

This case was keenly watched by both pharma industry and health activists because it had much wider ramifications.

The Delhi High Court (HC) on Tuesday dismissed German drug major Bayer Healthcare’s attempt to stop Drug Controller General of India (DCGI)...

The bid is scheduled to open in the first week of November. Germany, which is the world’s second largest drug market, looks for ways to cur...

Leading Indian drug makers with a large presence in Germany could face substantial pressure on margins following a recent tender by a Germa...